Sandra Levy
ARTICLES BY THIS AUTHOR
- 11/5/2019
RedHill Biopharma gets FDA green light for Talicia
RedHill's Talicia is the first and only FDA approved rifabutin-based H. pylori infection therapy. - 11/4/2019
FDA approves Sanofi’s Fluzone High Dose Quadrivalent
Sanofi’s Fluzone High-Dose Quadrivalent is used in people age 65 and older, to protect against influenza A and B strains. - 11/4/2019
CVS Health, UPS make first residential drone deliveries of prescriptions
CVS has initiated residential drone delivery of prescriptions via UPS Flight Forward, from a CVS pharmacy in North Carolina. - 11/4/2019
Sandoz gets FDA green light for Neulasta biosimilar Ziextenzo
With the FDA approval of Ziextenzo — a biosimilar of Neulasta — Sandoz is the first and only company to offer long- and short-acting filgrastim biosimilar treatment options. - 11/3/2019
FDA approves third indication for Lupin’s generic Levoxyl
Lupin's levothyroxine sodium tablets now is approved as a generic of Synthroid, Unithroid, and Levoxyl. - 11/3/2019
Endo implements CEO succession plan
Paul Campanelli has been named Endo chairman of the board, and will continue as president and CEO until a successor is appointed. - 11/3/2019
Camber gets FDA nod for generic Bentyl
Generic Bentyl is Camber's first injectable product to hit the market. - 10/31/2019
President Trump to nominate oncologist Stephen Hahn as FDA commissioner
President Trump will nominate Stephen Hahn, chief medical executive at The University of Texas MD Anderson Cancer Center, as FDA commissioner. - 10/31/2019
Hy-Vee, customers to honor veterans, active-duty military members, and families
Hy-Vee will match customer donations up to $100,000, during its seventh annual Hy-Vee Homefront Round Up this month. - 10/30/2019
SunGen gets FDA nod for lidocaine ointment
Lidocaine has a market value of about $60 million.
